1417576-01-2 Usage
Description
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate is a complex organic compound characterized by its long and specific molecular structure. It is composed of various functional groups, such as ester, carbonyl, ethoxy, oxadiazol, and biphenyl, which are reflected in its chemical name. The presence of these functional groups suggests that this compound may have potential pharmaceutical or research applications, although further study is required to understand its specific properties and potential uses.
Uses
Used in Pharmaceutical Applications:
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate is used as a pharmaceutical agent for its potential therapeutic effects. (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate's intricate structure and functional groups may contribute to its ability to interact with biological targets, making it a candidate for the development of new drugs.
Used in Research Applications:
In the field of research, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate serves as a valuable compound for studying the properties and interactions of complex organic molecules. Its unique structure allows researchers to explore its potential applications in various scientific disciplines, such as chemistry, biology, and materials science.
Used in Chemical Synthesis:
(5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate can be used as a building block or intermediate in the synthesis of other complex organic compounds. Its functional groups and structural features make it a versatile component in the creation of new molecules with specific properties and applications.
Used in Material Science:
In the field of material science, (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 2-ethoxy-1-((2′-(4-ethyl-5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-biphenyl-4-yl)methyl)-1H-benzo[d]imidazole-7-carboxylate may be utilized in the development of advanced materials with unique properties. Its functional groups and molecular structure could contribute to the creation of materials with specific characteristics, such as improved stability, reactivity, or selectivity, depending on the intended application.
Check Digit Verification of cas no
The CAS Registry Mumber 1417576-01-2 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,4,1,7,5,7 and 6 respectively; the second part has 2 digits, 0 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1417576-01:
(9*1)+(8*4)+(7*1)+(6*7)+(5*5)+(4*7)+(3*6)+(2*0)+(1*1)=162
162 % 10 = 2
So 1417576-01-2 is a valid CAS Registry Number.
1417576-01-2Relevant articles and documents
Improved process for azilsartan medoxomil: A new angiotensin receptor blocker
Radl, Stanislav,Cerny, Josef,Stach, Jan,Gablikova, Zuzana
, p. 77 - 86 (2013/03/28)
An improved process for the active pharmaceutical ingredient of a new angiotensin II AT1 receptor antagonist, azilsartan medoxomil, has been developed. The results include reinvestigation of the described process as well as its novel modifications. This new process includes transformation of the CN group into amidoxime moiety by aqueous hydroxylamine, its cyclization into the corresponding oxadiazole by treatment with dialkyl carbonates, and the following hydrolysis of the ester and transformation into the medoxomil ester. Several thus far undocumented side products were identified, and some of them were synthesized and duly characterized as potential impurities. Formation and control of possible critical impurities are described.
